Description

The session will demonstrate how clinical research has been integral to advancing the practice of radiation oncology and patient care by systematically testing new and novel radiotherapy approaches and evaluating the integration of optimized radiotherapy with new classes of anti-cancer therapies. Multi-center clinical trial results that set new standards of patient care in the recent past will be reviewed.  The future direction of radiotherapy research will be presented including examples of clinical trials underway evaluating new modalities and testing molecularly targeted therapies. Future clinical research challenges and opportunities will be discussed with emphasis on the critical expertise that will be needed.    

Subspecialties: RO
Modalities: NI

Speaker(s):

• Christopher Crane, MD
• Simon Lo, MB, ChB, FACR
• Mitchell Machtay, MD
• Seth Rosenthal, MD, FACR
• William Small, MD, FACR

Disclosures

• Mitchell Machtay, MD : Honoraria: Bristol-Myers Squibb, Eli Lily and Company,  Abbvie; Stock Options: Merck Oncology
• William Small, MD, FACR : Speakers Bureau: Zeiss
• Simon Lo, MB, ChB, FACR : Honoraria: Varian Medical Systems; Research Grants: Elekta AB
• Christopher Crane, MD : Consultant: Vertex